- Analogues of glucagon-like peptide in clinical practice 20102011 | Second Faculty of Medicine
- Nová forma glukagonu - práškový glukagon pro nosní aplikaci2020 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Physical Education and Sport
- Glucagon - nasal form2020 | Second Faculty of Medicine, Third Faculty of Medicine
- Cardiovascular effects of glukagon-like peptide-1 and its agonist: more than just cardiovascularly safe antidiabetics?2012 | First Faculty of Medicine
- Glucagon in treatment of hypoglycemia - novelties2021 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Physical Education and Sport
- Glucagon and Related Matters1999 | Second Faculty of Medicine
- Glucose release as a response to glucagon in rat hepatocyte culture: Involvement of NO signaling2008 | First Faculty of Medicine
- Glucagon-like peptide-1 and its significance in current diabetology2011 | First Faculty of Medicine
- Komentář ke studii (Adherence a perzistence na léčbě u pacientů s diabetes mellitus 2. typu léčených agonisty receptorů pro glukagon-like peptid-1)2018 | First Faculty of Medicine
- Incretin mimetics in the treatment of type 2 diabetes2014 | Faculty of Medicine in Hradec Králové
- Incretin hormones and the role of incretin mimetics in the treatment of type 2 diabetes mellitus2006 | Second Faculty of Medicine
- Management of hypoglycaemia in everyday clinical practice2019 | Second Faculty of Medicine, Third Faculty of Medicine
- Exenatid and its position as antidiabetic drug in the treatment of type 2 diabetes mellitus2008 | Second Faculty of Medicine
- Teduglutide, a glucagon-like peptide-2 analogue (REVESTIVE), in the treatment of short bowel syndrome with dependence on home parenteral nutrition2021 | First Faculty of Medicine
- Blokáda glukagonových receptorů v léčbě diabetu 1. typu2018 | Second Faculty of Medicine
- Nové molekuly pro terapii diabetu vyvíjené inovativními farmaceutickými společnostmi2017 | Second Faculty of Medicine
- Cardiovascular effects of GLP-1 receptor agonist treatment: focus on liraglutide2015 | First Faculty of Medicine
- Teduglutide therapy in patients with short bowel syndrome2021 | Second Faculty of Medicine
- Současná léčba diabetické nefropatie2020 | First Faculty of Medicine
- Some aspects of severe hypogylcaemia with the need of Emergency Medical Service activation2011 | Faculty of Pharmacy in Hradec Králové
- Exenatide2008 | Second Faculty of Medicine
- Sitagliptin versus semaglutide in type 2 diabetes mellitus2020 | Second Faculty of Medicine
- Role of incretins in energy metabolism and weight changes after smoking cessation2016 | First Faculty of Medicine
- Diabetic kidney disease and new antidibetics2019 | Second Faculty of Medicine
- komentář ke studii2017 | Second Faculty of Medicine
- Intenzifikace injekční léčby diabetes mellitus 2. typu2019 | Second Faculty of Medicine
- Use incretins for the treatment of diabetes 2. type2008 | Second Faculty of Medicine
- Agonization of GLP-1 in cardiology2020 | Faculty of Medicine in Pilsen
- Therapy based on the incretin effect2009 | Second Faculty of Medicine
- Konečně účinná farmakoterapie obezity?2023 | First Faculty of Medicine
